Niaid CRMS kerberos for sharepoint - services to support implementation of kerberos based authentication for niaid's clinical research management system (CRMS)
Ended Awarded Last action
- Contract number
- 75N93021F00187
- Awardee
-
Digital Infuzion, LLC UEI RVPLTBKK5287
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $59,856
Award facts
- Opportunity
-
- RFQ1486143 Solicitation number
- Contract value 100% obligated
- $59,855.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541511 Custom Computer Programming Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Gaithersburg, MD 20878, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$81 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $59,937 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $59,855.69 to Digital Infuzion, LLC for services supporting the implementation of Kerberos-based authentication for NIAID's Clinical Research Management System (CRMS). The contract was awarded on May 3, 2021, with a completion date of March 31, 2022, and is structured as a labor-hours engagement under a General Services Administration Multiple Award Schedule (MAS). Digital Infuzion, a minority-owned small business based in Rockville, Maryland, specializes in providing advanced information technology services to federal healthcare agencies, with particular expertise in clinical research management systems and healthcare database solutions.
This delivery order was issued under the FY26 Unexpired Deferral Obligation (UDO) initiative to administratively de-obligate unexpiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a). The work was performed in North Potomac, Maryland. No set-aside designation was applied to this contract award. Digital Infuzion's selection aligns with NIAID's broader clinical research IT infrastructure modernization efforts and reflects the company's established track record supporting complex healthcare and clinical research systems across multiple National Institutes of Health entities.
Quick answers
Who was awarded contract 75N93021F00187?
75N93021F00187 was awarded to Digital Infuzion, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 3, 2021.
How much is contract 75N93021F00187 worth?
The government has obligated $59,856 on 75N93021F00187.
Is contract 75N93021F00187 an order under another contract?
Yes. 75N93021F00187 is a delivery order under 47QTCA19D00FW, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N93021F00187 competed?
The extent of competition for 75N93021F00187 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award